18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
Radiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive determination of integrin αvβ3 expression in tumors. In this study, we performed radiosynthesis and biological evaluation of a new 18F-labeled RGD homodimeric peptide with one 8-amino-3,6-dioxaoctanoic acid (PEG...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4580323?pdf=render |
_version_ | 1819066101318811648 |
---|---|
author | Kongzhen Hu Xiaolan Tang Ganghua Tang Shaobo Yao Baoguo Yao Hongliang Wang Dahong Nie Xiang Liang Caihua Tang Shanzhen He |
author_facet | Kongzhen Hu Xiaolan Tang Ganghua Tang Shaobo Yao Baoguo Yao Hongliang Wang Dahong Nie Xiang Liang Caihua Tang Shanzhen He |
author_sort | Kongzhen Hu |
collection | DOAJ |
description | Radiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive determination of integrin αvβ3 expression in tumors. In this study, we performed radiosynthesis and biological evaluation of a new 18F-labeled RGD homodimeric peptide with one 8-amino-3,6-dioxaoctanoic acid (PEG2) linker on the glutamate β-amino group (18F-FP-PEG2-β-Glu-RGD2) as a symmetric PET tracer for tumor imaging. Biodistribution studies showed that radioactivity of 18F-FP-PEG2-β-Glu-RGD2 was rapidly cleared from blood by predominately renal excretion. MicroPET-CT imaging with 18F-FP-PEG2-β-Glu-RGD2 revealed high tumor contrast and low background in A549 human lung adenocarcinoma-bearing mouse models, PC-3 prostate cancer-bearing mouse models, and orthotopic transplanted C6 brain glioma models. 18F-FP-PEG2-β-Glu-RGD2 exhibited good stability in vitro and in vivo. The results suggest that this tracer is a potential PET tracer for tumor imaging. |
first_indexed | 2024-12-21T15:57:00Z |
format | Article |
id | doaj.art-5e2e448d258b4ec69ecdb3b49b24e7b9 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-21T15:57:00Z |
publishDate | 2015-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-5e2e448d258b4ec69ecdb3b49b24e7b92022-12-21T18:58:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013867510.1371/journal.pone.013867518F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.Kongzhen HuXiaolan TangGanghua TangShaobo YaoBaoguo YaoHongliang WangDahong NieXiang LiangCaihua TangShanzhen HeRadiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive determination of integrin αvβ3 expression in tumors. In this study, we performed radiosynthesis and biological evaluation of a new 18F-labeled RGD homodimeric peptide with one 8-amino-3,6-dioxaoctanoic acid (PEG2) linker on the glutamate β-amino group (18F-FP-PEG2-β-Glu-RGD2) as a symmetric PET tracer for tumor imaging. Biodistribution studies showed that radioactivity of 18F-FP-PEG2-β-Glu-RGD2 was rapidly cleared from blood by predominately renal excretion. MicroPET-CT imaging with 18F-FP-PEG2-β-Glu-RGD2 revealed high tumor contrast and low background in A549 human lung adenocarcinoma-bearing mouse models, PC-3 prostate cancer-bearing mouse models, and orthotopic transplanted C6 brain glioma models. 18F-FP-PEG2-β-Glu-RGD2 exhibited good stability in vitro and in vivo. The results suggest that this tracer is a potential PET tracer for tumor imaging.http://europepmc.org/articles/PMC4580323?pdf=render |
spellingShingle | Kongzhen Hu Xiaolan Tang Ganghua Tang Shaobo Yao Baoguo Yao Hongliang Wang Dahong Nie Xiang Liang Caihua Tang Shanzhen He 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. PLoS ONE |
title | 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. |
title_full | 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. |
title_fullStr | 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. |
title_full_unstemmed | 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. |
title_short | 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. |
title_sort | 18f fp peg2 β glu rgd2 a symmetric integrin αvβ3 targeting radiotracer for tumor pet imaging |
url | http://europepmc.org/articles/PMC4580323?pdf=render |
work_keys_str_mv | AT kongzhenhu 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT xiaolantang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT ganghuatang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT shaoboyao 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT baoguoyao 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT hongliangwang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT dahongnie 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT xiangliang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT caihuatang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging AT shanzhenhe 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging |